Selected research
Industry Growth & Trends
Global Minimally Invasive Treatment of Lung Cancer Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Minimally Invasive Treatment of Lung Cancer market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Minimally Invasive Treatment of Lung Cancer is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Minimally Invasive Treatment of Lung Cancer is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Minimally Invasive Treatment of Lung Cancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Minimally Invasive Treatment of Lung Cancer market include Medtronic, LungCare, Broncus, Boston Scientific, Olympus, VISON Medical, Smith and Nephew, Nanjing MICRO-TECH and Intuitive Surgica, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Minimally Invasive Treatment of Lung Cancer market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Minimally Invasive Treatment of Lung Cancer market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Minimally Invasive Treatment of Lung Cancer market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Minimally Invasive Treatment of Lung Cancer.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Minimally Invasive Treatment of Lung Cancer market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Minimally Invasive Treatment of Lung Cancer Market by Company
Medtronic
LungCare
Broncus
Boston Scientific
Olympus
VISON Medical
Smith and Nephew
Nanjing MICRO-TECH
Intuitive Surgica
Auris Health
Angiodynamics
Minimally Invasive Treatment of Lung Cancer Segment by Type
Lung Tumor Ablation
Lung Tumor Embolization
Minimally Invasive Treatment of Lung Cancer Segment by Application
Hospitals
Ambulatory Surgical Centers
Minimally Invasive Treatment of Lung Cancer Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Minimally Invasive Treatment of Lung Cancer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Minimally Invasive Treatment of Lung Cancer and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Minimally Invasive Treatment of Lung Cancer.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Minimally Invasive Treatment of Lung Cancer companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Lung Tumor Ablation
- Lung Tumor Embolization
Applications
- Hospitals
- Ambulatory Surgical Centers
Companies covered
- Medtronic
- LungCare
- Broncus
- Boston Scientific
- Olympus
- VISON Medical
- Smith and Nephew
- Nanjing MICRO-TECH
- Intuitive Surgica
- Auris Health
- Angiodynamics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Minimally Invasive Treatment of Lung Cancer Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Minimally Invasive Treatment of Lung Cancer Market Size by Region (2021-2032)
- 1.4.1 Global Minimally Invasive Treatment of Lung Cancer Market Size by Region (2021-2026)
- 1.4.2 Global Minimally Invasive Treatment of Lung Cancer Market Size by Region (2027-2032)
- 1.5 Key Regions Minimally Invasive Treatment of Lung Cancer Market Size (2021-2032)
- 1.5.1 North America Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate (2021-2032)
- 1.5.4 South America Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate (2021-2032)
2 Minimally Invasive Treatment of Lung Cancer Market by Type
- 2.1 Type Introduction
- 2.1.1 Lung Tumor Ablation
- 2.1.2 Lung Tumor Embolization
- 2.2 Global Minimally Invasive Treatment of Lung Cancer Market Size by Type
- 2.2.1 Global Minimally Invasive Treatment of Lung Cancer Market Size Overview by Type (2021-2032)
- 2.2.2 Global Minimally Invasive Treatment of Lung Cancer Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Minimally Invasive Treatment of Lung Cancer Market Size Forecasted by Type (2027-2032)
- 2.3 Global Minimally Invasive Treatment of Lung Cancer Market Size by Regions
- 2.3.1 North America Minimally Invasive Treatment of Lung Cancer Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Minimally Invasive Treatment of Lung Cancer Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Minimally Invasive Treatment of Lung Cancer Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Minimally Invasive Treatment of Lung Cancer Market Size Breakdown by Type (2021-2026)
3 Minimally Invasive Treatment of Lung Cancer Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospitals
- 3.1.2 Ambulatory Surgical Centers
- 3.2 Global Minimally Invasive Treatment of Lung Cancer Market Size by Application
- 3.2.1 Global Minimally Invasive Treatment of Lung Cancer Market Size Overview by Application (2021-2032)
- 3.2.2 Global Minimally Invasive Treatment of Lung Cancer Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Minimally Invasive Treatment of Lung Cancer Market Size Forecasted by Application (2027-2032)
- 3.3 Global Minimally Invasive Treatment of Lung Cancer Market Size by Regions
- 3.3.1 North America Minimally Invasive Treatment of Lung Cancer Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Minimally Invasive Treatment of Lung Cancer Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Minimally Invasive Treatment of Lung Cancer Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Minimally Invasive Treatment of Lung Cancer Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Minimally Invasive Treatment of Lung Cancer Industry Trends
- 4.2 Minimally Invasive Treatment of Lung Cancer Industry Drivers
- 4.3 Minimally Invasive Treatment of Lung Cancer Industry Opportunities and Challenges
- 4.4 Minimally Invasive Treatment of Lung Cancer Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Minimally Invasive Treatment of Lung Cancer Revenue (2021-2026)
- 5.2 Global Minimally Invasive Treatment of Lung Cancer Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Minimally Invasive Treatment of Lung Cancer Key Company Headquarters & Area Served
- 5.4 Global Minimally Invasive Treatment of Lung Cancer Company, Product Type & Application
- 5.5 Global Minimally Invasive Treatment of Lung Cancer Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Minimally Invasive Treatment of Lung Cancer Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Minimally Invasive Treatment of Lung Cancer Players Market Share by Revenue in 2025
- 5.6.3 2025 Minimally Invasive Treatment of Lung Cancer Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Medtronic
- 6.1.1 Medtronic Company Information
- 6.1.2 Medtronic Business Overview
- 6.1.3 Medtronic Minimally Invasive Treatment of Lung Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Medtronic Minimally Invasive Treatment of Lung Cancer Product Portfolio
- 6.1.5 Medtronic Recent Developments
- 6.2 LungCare
- 6.2.1 LungCare Company Information
- 6.2.2 LungCare Business Overview
- 6.2.3 LungCare Minimally Invasive Treatment of Lung Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 LungCare Minimally Invasive Treatment of Lung Cancer Product Portfolio
- 6.2.5 LungCare Recent Developments
- 6.3 Broncus
- 6.3.1 Broncus Company Information
- 6.3.2 Broncus Business Overview
- 6.3.3 Broncus Minimally Invasive Treatment of Lung Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Broncus Minimally Invasive Treatment of Lung Cancer Product Portfolio
- 6.3.5 Broncus Recent Developments
- 6.4 Boston Scientific
- 6.4.1 Boston Scientific Company Information
- 6.4.2 Boston Scientific Business Overview
- 6.4.3 Boston Scientific Minimally Invasive Treatment of Lung Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Boston Scientific Minimally Invasive Treatment of Lung Cancer Product Portfolio
- 6.4.5 Boston Scientific Recent Developments
- 6.5 Olympus
- 6.5.1 Olympus Company Information
- 6.5.2 Olympus Business Overview
- 6.5.3 Olympus Minimally Invasive Treatment of Lung Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Olympus Minimally Invasive Treatment of Lung Cancer Product Portfolio
- 6.5.5 Olympus Recent Developments
- 6.6 VISON Medical
- 6.6.1 VISON Medical Company Information
- 6.6.2 VISON Medical Business Overview
- 6.6.3 VISON Medical Minimally Invasive Treatment of Lung Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 VISON Medical Minimally Invasive Treatment of Lung Cancer Product Portfolio
- 6.6.5 VISON Medical Recent Developments
- 6.7 Smith and Nephew
- 6.7.1 Smith and Nephew Company Information
- 6.7.2 Smith and Nephew Business Overview
- 6.7.3 Smith and Nephew Minimally Invasive Treatment of Lung Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Smith and Nephew Minimally Invasive Treatment of Lung Cancer Product Portfolio
- 6.7.5 Smith and Nephew Recent Developments
- 6.8 Nanjing MICRO-TECH
- 6.8.1 Nanjing MICRO-TECH Company Information
- 6.8.2 Nanjing MICRO-TECH Business Overview
- 6.8.3 Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Product Portfolio
- 6.8.5 Nanjing MICRO-TECH Recent Developments
- 6.9 Intuitive Surgica
- 6.9.1 Intuitive Surgica Company Information
- 6.9.2 Intuitive Surgica Business Overview
- 6.9.3 Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Product Portfolio
- 6.9.5 Intuitive Surgica Recent Developments
- 6.10 Auris Health
- 6.10.1 Auris Health Company Information
- 6.10.2 Auris Health Business Overview
- 6.10.3 Auris Health Minimally Invasive Treatment of Lung Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Auris Health Minimally Invasive Treatment of Lung Cancer Product Portfolio
- 6.10.5 Auris Health Recent Developments
- 6.11 Angiodynamics
- 6.11.1 Angiodynamics Company Information
- 6.11.2 Angiodynamics Business Overview
- 6.11.3 Angiodynamics Minimally Invasive Treatment of Lung Cancer Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Angiodynamics Minimally Invasive Treatment of Lung Cancer Product Portfolio
- 6.11.5 Angiodynamics Recent Developments
7 North America
- 7.1 North America Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021-2026)
- 7.3 North America Minimally Invasive Treatment of Lung Cancer Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021-2026)
- 8.3 Europe Minimally Invasive Treatment of Lung Cancer Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021-2026)
- 10.3 South America Minimally Invasive Treatment of Lung Cancer Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst